US$ 23.14
glutathione reaction hepatic Changes in Content in Liver Diseases: An Update Frontiers | Research progress of
Description
A planned sample size of 190 subjects with complete observations yielded 80% power at the 5% two-sided significance level to detect a difference in the primary endpoint (hospitalization) rate of 10% in the resveratrol arm versus 25% in the placebo arm

doi: 10.1124/jpet.102.045153
This article aims to shed light on the two popular methods of glutathione administration: intravenous (IV) drips and oral capsules, offering insights to help individuals make informed decisions about their health

Returning to the intestinal microbiota, several lines of evidence suggest that obesity-related NAFLD could impact on patients who habitually use/abuse opioids

& Bannai, S

Biochem Biophys Res Commun 307: 973979, 2003
